MetaVia MTVA
NASDAQ MTVA
$1.46 +0.02 (+1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

MetaVia (MTVA) Cash & Current Investments (2015 - 2026)

MetaVia's (MTVA) quarterly Cash & Current Investments came in at $10.3 million in Q4 2025, down 35.56% YoY from $16.0 million in Q4 2024, and down 27.78% on a QoQ basis from $14.3 million in Q3 2025.

MetaVia (MTVA) Cash & Current Investments (2015 - 2026) Analysis & Trends

MetaVia (MTVA) has 11 years of Cash & Current Investments data on file, last reported at $10.3 million in Q4 2025.

  • Quarterly Cash & Current Investments fell 35.56% year-over-year to $10.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.3 million (down 35.56% YoY) and the FY2025 annual result came in at $10.3 million, down 35.56% from the prior year.
  • Cash & Current Investments slipped to $10.3 million in Q4 2025, from $14.3 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $33.4 million in Q4 2022 to a low of $6.4 million in Q3 2022.
  • A 5-year average of $17.5 million and a median of $16.0 million in 2024 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2021 — Cash & Current Investments surged 86800.0% — and 2024, when it tumbled 48.11%.
  • Tracing MTVA's Cash & Current Investments over 5 years: stood at $16.4 million in 2021, then jumped by 103.6% to $33.4 million in 2022, then tumbled by 32.64% to $22.5 million in 2023, then declined by 28.66% to $16.0 million in 2024, then sank by 35.56% to $10.3 million in 2025.
  • The last three Cash & Current Investments figures came in at $10.3 million (Q4 2025), $14.3 million (Q3 2025), and $17.6 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.14 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 3.31 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 18.39 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.16 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 836.99 Mn
10 MetaVia 8.72 Mn -3.92 Mn - 12.64 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 12.64 Mn
Dec 31, 2025 10.33 Mn
Sep 30, 2025 14.31 Mn
Jun 30, 2025 17.60 Mn
Mar 31, 2025 11.19 Mn
Dec 31, 2024 16.03 Mn
Sep 30, 2024 21.71 Mn
Jun 30, 2024 28.05 Mn
Mar 31, 2024 15.99 Mn
Dec 31, 2023 22.47 Mn
Sep 30, 2023 25.84 Mn
Jun 30, 2023 28.69 Mn
Mar 31, 2023 30.81 Mn
Dec 31, 2022 33.36 Mn
Sep 30, 2022 6.40 Mn
Jun 30, 2022 8.85 Mn
Mar 31, 2022 11.60 Mn
Dec 31, 2021 16.39 Mn
Sep 30, 2021 7.00 Mn
Jun 30, 2021 9.50 Mn